# Evidence search
(under construction)
## Inclusion criteria
Randomized trials of amy cancer that compare pembrolizumab to placebo or another active treatment.

## Reconciliation tables
(under construction)
* [Comparison of included studies with prior systematic reviews](../reconciliation-tables)

## PubMed
### Boolean term searching
(under construction)
[pembrolizumab AND random\*](https://www.ncbi.nlm.nih.gov/pubmed?cmd=Search&term=pembrolizumab%20AND%20random*)
* Retrieves X articles in hand (100% sensitivity) (search 6/19/2017)
* X total citations found (search results reviewed 6/x/2017; 0 additional studies found)

### Vector searching ('Related citations' search)
(under construction)
Seed articles: PMIDs [26314489,28552271,28140013,9851958,2897005](https://www.ncbi.nlm.nih.gov/pubmed?cmd=Search&tool=SUMSearch2plugins&otool=kumclib&term=26314489%2028552271%2028140013%209851958%202897005)
* [204 citations](https://www.ncbi.nlm.nih.gov/pubmed?linkname=pubmed_pubmed&from_uid=26314489,28552271,28140013,9851958,2897005)
* NA citations when above limited to years 2014 - 2017 (time period after Cochrane review)
  * [X additional articles found](https://www.ncbi.nlm.nih.gov/pubmed?linkname=pubmed_pubmed&from_uid=15570651)

## ClinicalTrials.gov

`pembrolizumab abd cancer`
* [889 citations](https://clinicaltrials.gov/ct2/results?term=pembrolizumab&type=Intr&cond=cancer) (search 6/19/2017)
  * [NCT02216240](https://clinicaltrials.gov/ct2/show/NCT02216240) (PMID [27613170](https://www.ncbi.nlm.nih.gov/pubmed/27613170)) did not meet inclusion criteria

## Cochrane Central Register of Controlled Trials (CENTRAL)

`pembrolizumab`
* [665 citations](https://www.cochranelibrary.com/en/search?searchBy=1&searchText=pembrolizumab&isWordVariations=&resultPerPage=25&searchType=basic&forceTypeSelection=true&selectedType=central&displayText=&p_p_id=scolarissearchresultsportlet_WAR_scolarissearchresults&p_p_lifecycle=0&p_p_state=normal&p_p_mode=view&p_p_col_id=column-1&p_p_col_count=1 (search 12/13/2018)
  * [http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD005182/abstract](http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD005182.pub4/full) (PMID [27613170](https://www.ncbi.nlm.nih.gov/pubmed/27613170)) did not meet inclusion criteria

## Cited reference searching
(under construction)

### Identifying seminal studies that are the most highly cited
Smith GD, Dyson K, Taylor D, Morgans A, Cantwell K. Effectiveness of the Valsalva Manoeuvre for reversion of supraventricular tachycardia. Cochrane Database Syst Rev. 2013 Mar 28;(3):CD009502. doi: 10.1002/14651858.CD009502.pub2. Review. Update in: Cochrane Database Syst Rev. 2015 PMID: [23543578](http://pubmed.gov/23543578).
 * [17 citations](https://scholar.google.com/scholar?cites=2217747907445562937&as_sdt=2005&sciodt=0,5&hl=en) (search 6/19/2017)

Mehta D, Wafa S, Ward DE, Camm AJ. Relative efficacy of various physical manoeuvres in the termination of junctional tachycardia. Lancet. 1988.PMID: [2897005](http://pubmed.gov/2897005).
 * [105 citations ](https://scholar.google.com/scholar?cites=7605211014335624801) (search 6/19/2017)

### Searching 'random*' within the highly citing studyies using Google Scholar (4/21/2017)
Mehta et al. 
* [12 citations](https://scholar.google.com/scholar?q=random&btnG=&hl=en&as_sdt=0%2C5&sciodt=0%2C5&cites=7605211014335624801&scipsc=1) (limited to citing articles containing random\*)
* [x additional studies found](https://pubmed.gov/25503625,27045252)

## Other websites:

### ASCO
https://meetinglibrary.asco.org/results/Keywords:%22pembrolizumab%22%20AND%20Keywords:%22randomized%22%20AMD%20%28Keywords:%22HR%22%20OR%20Keywords:%22hazard%22%29

#### Merck
https://www.merck.com/clinical-trials/infographics/oncology.html
